Table 3. Summary of the optimised protocols proposed by the model.
|
Etoposide |
Cisplatin |
|||
|---|---|---|---|---|
| Protocol | Time | Dose | Time | Dose |
| OP1 | 0–1 h | 80 mg m−2 | 1–2 h | 80 mg m−2 |
| 12–84 h | 160 mg m−2 | |||
| OP2 (intensified) | 0–1 h | 80 mg m−2 | 1–2 h | 80 mg m−2 |
| 12–108 h | 300 mg m−2 | |||
| OP3 (14-day cycle) | 0–1 h | 40 mg m−2 | 1–2 h | 50 mg m−2 |
| 6–78 h | 105 mg m−2 | |||